Last reviewed · How we verify
Bravavir (SORIVUDINE)
Bravavir (generic name: SORIVUDINE) is a sorivudine drug. It is currently FDA-approved.
Bravavir, also known as sorivudine, is a small molecule inhibitor of the DNA polymerase catalytic subunit. It has been studied in clinical trials for various conditions, including Herpes Zoster, Postherpetic Neuralgia, HIV Infections, Chickenpox, and Metastatic Breast Cancer.
At a glance
| Generic name | SORIVUDINE |
|---|---|
| Drug class | sorivudine |
| Target | Thymidine kinase, mitochondrial, Deoxynucleoside kinase, Thymidine kinase |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients (PHASE2)
- Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients (PHASE2)
- Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) (PHASE2)
- A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bravavir CI brief — competitive landscape report
- Bravavir updates RSS · CI watch RSS
Frequently asked questions about Bravavir
What is Bravavir?
What is the generic name of Bravavir?
What drug class is Bravavir in?
What development phase is Bravavir in?
What does Bravavir target?
Related
- Drug class: All sorivudine drugs
- Target: All drugs targeting Thymidine kinase, mitochondrial, Deoxynucleoside kinase, Thymidine kinase
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing